Australian experience with ibrutinib in patients with relapsed/refractory mantle cell lymphoma: a study from the Lymphoma and Related Diseases Registry
Details
Publication Year 2023,Volume 64,Issue #3,Page 621-627
Journal Title
Leukemia & Lymphoma
Publication Type
Research article
Publisher
Taylor & Francis
Department(s)
Clinical Haematology
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2024-01-16 04:29:25
Last Modified: 2024-01-16 04:53:14
An error has occurred. This application may no longer respond until reloaded. Reload 🗙